Stay updated on 12-Week Psoriasis Dose-Ranging Clinical Trial
Sign up to get notified when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.

Latest updates to the 12-Week Psoriasis Dose-Ranging Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4. No content changes are indicated.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.3.3 to the page footer. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Publications section description was updated to indicate automatic population from PubMed. The revision label was updated to v3.3.2, replacing the previous v3.2.0 wording.SummaryDifference0.1%

- Check66 days agoChange DetectedThe funding-status notice at the top of the page was removed, while the rest of the study details (title, eligibility criteria, contacts) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedMinor UI/layout adjustments observed; no changes to core study content (title, conditions, interventions, outcomes, eligibility, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check109 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference4%

Stay in the know with updates to 12-Week Psoriasis Dose-Ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.